Loading
BI
Bioverativ Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Posner Brian S, was filed 10 Aug 2017.
Bioverativ Inc.: what insiders have been doing
Every trade that managers of Bioverativ Inc. disclose to SEC (Form 4) is tracked on this page. Bioverativ Inc. has had no insider filing for more than a year; the last one goes back to 8 March 2018.
Since 2017, the database holds 9 purchases and 1 sale by insiders of the company.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
100
Thresholds
n/a
Buy Volume
€51M
9 ops. · all time
Sell Volume
€43,456
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Revenue1B
Gross profit792.4M76% margin
Net income317M30.4% margin
Last declaration on 8 March 2018
Declarations100 total
838.95 sharesCommon StockSEC:0001127602-18-010666:0
22,952 sharesCommon StockSEC:0001127602-18-010636:0
2,791 sharesCommon StockSEC:0001127602-18-010658:0
5,001 sharesCommon StockSEC:0001127602-18-010651:0
1,165,000 sharesCommon StockSEC:0001127602-18-010651:1
6,693 sharesCommon StockSEC:0001127602-18-010675:0
2,000 shares0Common StockSEC:0001127602-18-010671:0
3,056 sharesCommon StockSEC:0001127602-18-010671:1
20,396.25 sharesCommon StockSEC:0001127602-18-010641:0
5,951.01 sharesCommon StockSEC:0001127602-18-010664:0
1,056 sharesCommon StockSEC:0001127602-18-010677:0
30,600.2 sharesCommon StockSEC:0001127602-18-010654:0
5,758.04 sharesCommon StockSEC:0001127602-18-010645:0
105 shares@ US$104.737.2% of flowCommon StockSEC:0001127602-18-010132:0
2,011 shares@ US$104.3028.6% of flowCommon StockSEC:0001127602-18-008437:0
917 shares@ US$104.7413.0% of flowCommon StockSEC:0001127602-18-008437:1
168 shares@ US$104.3011.4% of flowCommon StockSEC:0001127602-18-008447:0
1,235 shares@ US$104.3026.2% of flowCommon StockSEC:0001127602-18-008440:0
389 shares@ US$104.748.3% of flowCommon StockSEC:0001127602-18-008440:1
1,419 shares@ US$104.3023.7% of flowCommon StockSEC:0001127602-18-008433:0
924 shares@ US$104.7415.5% of flowCommon StockSEC:0001127602-18-008433:1
3,744 shares0Common StockSEC:0001127602-18-006421:0
25 of 100 declarations
About Bioverativ Inc.
Bioverativ Inc. is a biopharmaceutical company focused on developing treatments for blood disorders, including hemophilia. It was founded in 2017 and is listed on the NASDAQ.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
